Related Experiment Videos
[Hyperthyroidism in thyroid cancer. Retrospective study of 53 cases]
Nuklearmedizin. Nuclear Medicine
|December 1, 1984
Summary
Hyperthyroidism co-occurring with thyroid cancer is uncommon, affecting 19.5% of patients. Differentiating benign toxic adenomas from malignant hot nodules requires specific clinical and imaging criteria.
Area of Science:
- Endocrinology
- Oncology
- Nuclear Medicine
Background:
- Hyperthyroidism is a condition characterized by an overactive thyroid gland.
- Thyroid carcinoma, or thyroid cancer, involves the abnormal growth of cells in the thyroid gland.
- The co-occurrence of hyperthyroidism and thyroid carcinoma presents diagnostic challenges.
Observation:
- This study examined 273 thyroid carcinoma patients, diagnosing hyperthyroidism in 53 (19.5%) at initial examination.
- Hyperthyroidism and thyroid carcinoma were distinct in 24 patients (Graves' disease, Plummer's disease with separate nodules).
- In 29 patients, hyperthyroidism and carcinoma were linked, often within a solitary toxic adenoma where the hot nodule was malignant.
Findings:
- Malignant hot nodules within toxic adenomas were identified in 29 patients (55% of hyperthyroid cases).
- Histological confirmation of malignancy in the hot nodule was achieved in 10 of 24 cases.
- Malignant hot tumors are estimated to occur in 1 out of every 50 benign toxic adenomas.
Implications:
- Early identification of malignant hot nodules is crucial for effective thyroid cancer treatment.
- Clinical criteria like rapid nodule growth, large size (>5 cm or >35g), and specific T3 levels aid differentiation.
- Further research is needed to refine diagnostic strategies for co-existing hyperthyroidism and thyroid cancer.